Immunoliposomes: a new therapeutic option to treat SynGAP1-associated epilepsy

The blood-brain barrier (BBB) hinders the uptake of most drugs into the brain. Thus, active processes, physiologically necessary for nutrient uptake, like receptor-mediated transcytosis have become popular targets for drug transport. One such receptor is the transferrin receptor 1 (TfR), being highl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wienken, Katharina (VerfasserIn) , Mazur, A. (VerfasserIn) , Gericke, Birthe (VerfasserIn) , Petralla, Sabrina (VerfasserIn) , Wagner, Lelia (VerfasserIn) , Seifert, O. (VerfasserIn) , Kontermann, R. E. (VerfasserIn) , Fricker, Gert (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 2025
In: European journal of pharmaceutics and biopharmaceutics
Year: 2025, Jahrgang: 214, Pages: 1-11
ISSN:1873-3441
DOI:10.1016/j.ejpb.2025.114799
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejpb.2025.114799
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0939641125001766
Volltext
Verfasserangaben:K. Wienken, A. Mazur, B. Gericke, S. Petralla, L. Wagner, O. Seifert, R.E. Kontermann, G. Fricker

MARC

LEADER 00000caa a2200000 c 4500
001 1941479723
003 DE-627
005 20251120193745.0
007 cr uuu---uuuuu
008 251118s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejpb.2025.114799  |2 doi 
035 |a (DE-627)1941479723 
035 |a (DE-599)KXP1941479723 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Wienken, Katharina  |d 1996-  |e VerfasserIn  |0 (DE-588)135987724X  |0 (DE-627)1919822151  |4 aut 
245 1 0 |a Immunoliposomes  |b a new therapeutic option to treat SynGAP1-associated epilepsy  |c K. Wienken, A. Mazur, B. Gericke, S. Petralla, L. Wagner, O. Seifert, R.E. Kontermann, G. Fricker 
264 1 |c September 2025 
300 |b Diagramme 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 19. Juni 2025, Version des Artikels 5. Juli 2025 
500 |a Gesehen am 18.11.2025 
520 |a The blood-brain barrier (BBB) hinders the uptake of most drugs into the brain. Thus, active processes, physiologically necessary for nutrient uptake, like receptor-mediated transcytosis have become popular targets for drug transport. One such receptor is the transferrin receptor 1 (TfR), being highly expressed at the BBB. Immunoliposomes targeting the TfR were loaded with rosuvastatin to improve the therapy of SynGAP1-associated epilepsy. The rational of using rosuvastatin is based on its function downregulating the Ras-Raf-MEK-ERK pathway, which is upregulated in excitatory neurons in patients with SynGAP1-related disorders. However, rosuvastatin shows poor BBB permeability. Therefore, immunoliposomes decorated with anti-TfR antibody Ox26 and its single-chain variable fragment (scFv) were prepared and characterized. Immunoliposomes could be prepared reproducibly with a size of about 125 nm, were not hemolytically active and showed colloidal stability in plasma for 2 h. They exhibited a high uptake into endothelial cells which was not altered in presence of the natural ligand transferrin. In vivo application of fluorescently labeled immunoliposomes demonstrated a long plasma half-life and accumulation in brain capillaries. In comparison to unmodified liposomes, Ox26- and scFv-immunoliposomes showed a 2.8- and 2.5-fold improved transfer of rosuvastatin into brain tissue, suggesting successful passage of the BBB. 
650 4 |a Antibody decoration 
650 4 |a Blood-brain barrier 
650 4 |a Brain-targeting 
650 4 |a Immunoliposomes 
650 4 |a Nanomedicine 
650 4 |a Ox26 antibody 
650 4 |a Rosuvastatin 
650 4 |a SynGAP1 epilepsy 
650 4 |a Transferrin receptor 
700 1 |a Mazur, A.  |e VerfasserIn  |4 aut 
700 1 |a Gericke, Birthe  |e VerfasserIn  |0 (DE-588)132181108X  |0 (DE-627)1881697975  |4 aut 
700 1 |a Petralla, Sabrina  |e VerfasserIn  |0 (DE-588)1262403529  |0 (DE-627)181007066X  |4 aut 
700 1 |a Wagner, Lelia  |d 1994-  |e VerfasserIn  |0 (DE-588)1230491139  |0 (DE-627)1752949730  |4 aut 
700 1 |a Seifert, O.  |e VerfasserIn  |4 aut 
700 1 |a Kontermann, R. E.  |e VerfasserIn  |4 aut 
700 1 |a Fricker, Gert  |d 1956-  |e VerfasserIn  |0 (DE-588)1042227675  |0 (DE-627)768469465  |0 (DE-576)393783464  |4 aut 
773 0 8 |i Enthalten in  |t European journal of pharmaceutics and biopharmaceutics  |d New York, NY [u.a.] : Elsevier, 1997  |g 214(2025) vom: Sept., Artikel-ID 114799, Seite 1-11  |h Online-Ressource  |w (DE-627)300897324  |w (DE-600)1483524-1  |w (DE-576)259270822  |x 1873-3441  |7 nnas  |a Immunoliposomes a new therapeutic option to treat SynGAP1-associated epilepsy 
773 1 8 |g volume:214  |g year:2025  |g month:09  |g elocationid:114799  |g pages:1-11  |g extent:11  |a Immunoliposomes a new therapeutic option to treat SynGAP1-associated epilepsy 
856 4 0 |u https://doi.org/10.1016/j.ejpb.2025.114799  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0939641125001766  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251118 
993 |a Article 
994 |a 2025 
998 |g 1042227675  |a Fricker, Gert  |m 1042227675:Fricker, Gert  |d 160000  |d 160100  |e 160000PF1042227675  |e 160100PF1042227675  |k 0/160000/  |k 1/160000/160100/  |p 8  |y j 
998 |g 1230491139  |a Wagner, Lelia  |m 1230491139:Wagner, Lelia  |p 5 
998 |g 1262403529  |a Petralla, Sabrina  |m 1262403529:Petralla, Sabrina  |p 4 
998 |g 132181108X  |a Gericke, Birthe  |m 132181108X:Gericke, Birthe  |d 160000  |d 160100  |e 160000PG132181108X  |e 160100PG132181108X  |k 0/160000/  |k 1/160000/160100/  |p 3 
998 |g 135987724X  |a Wienken, Katharina  |m 135987724X:Wienken, Katharina  |p 1  |x j 
999 |a KXP-PPN1941479723  |e 4808232243 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title_sort":"Immunoliposomes","title":"Immunoliposomes","subtitle":"a new therapeutic option to treat SynGAP1-associated epilepsy"}],"name":{"displayForm":["K. Wienken, A. Mazur, B. Gericke, S. Petralla, L. Wagner, O. Seifert, R.E. Kontermann, G. Fricker"]},"person":[{"family":"Wienken","display":"Wienken, Katharina","role":"aut","given":"Katharina"},{"family":"Mazur","display":"Mazur, A.","role":"aut","given":"A."},{"family":"Gericke","given":"Birthe","role":"aut","display":"Gericke, Birthe"},{"role":"aut","given":"Sabrina","display":"Petralla, Sabrina","family":"Petralla"},{"family":"Wagner","display":"Wagner, Lelia","role":"aut","given":"Lelia"},{"given":"O.","role":"aut","display":"Seifert, O.","family":"Seifert"},{"display":"Kontermann, R. E.","role":"aut","given":"R. E.","family":"Kontermann"},{"display":"Fricker, Gert","role":"aut","given":"Gert","family":"Fricker"}],"origin":[{"dateIssuedDisp":"September 2025","dateIssuedKey":"2025"}],"recId":"1941479723","type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"note":["Gesehen am 25.05.2020"],"id":{"issn":["1873-3441"],"zdb":["1483524-1"],"eki":["300897324"]},"disp":"Immunoliposomes a new therapeutic option to treat SynGAP1-associated epilepsyEuropean journal of pharmaceutics and biopharmaceutics","physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"New York, NY [u.a.]","dateIssuedKey":"1997","publisher":"Elsevier","dateIssuedDisp":"1997-"}],"recId":"300897324","titleAlt":[{"title":"EJPB"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["Nachgewiesen 43.1997 -"],"language":["eng"],"part":{"pages":"1-11","extent":"11","volume":"214","text":"214(2025) vom: Sept., Artikel-ID 114799, Seite 1-11","year":"2025"},"title":[{"title_sort":"European journal of pharmaceutics and biopharmaceutics","subtitle":"EJPB ; official journal of the International Association for Pharmaceutical Technology","title":"European journal of pharmaceutics and biopharmaceutics"}]}],"note":["Online verfügbar: 19. Juni 2025, Version des Artikels 5. Juli 2025","Gesehen am 18.11.2025"],"physDesc":[{"noteIll":"Diagramme","extent":"11 S."}],"id":{"doi":["10.1016/j.ejpb.2025.114799"],"eki":["1941479723"]}} 
SRT |a WIENKENKATIMMUNOLIPO2025